Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.
Sign up to receive all grant announcements, including Request for Proposal (RFP) postings.
Sign Up for Alerts DetailsTitle | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
The Enhancement of Management of breast cancer in French speaking Sub-Saharan African Countries Release Date: Partner: AMFROM | Quality Improvement | Oncology | Benin, Congo, The Democratic Republic, Mali, Senegal, Togo | |
Improving Atopic Dermatitis and Alopecia Areata Quality of Care to Standardize Management Release Date: Partner: Beijing Guangda Precision Medicine Research Center | Quality Improvement | Inflammation & Immunology | China | |
Optimizing Antimicrobial Stewardship Program in Saudi Arabia Release Date: | Quality Improvement | Inflammation & Immunology | Saudi Arabia | |
Invasive Mold Infections (IMI) - Real-World Evidence from Treatment Outcomes with Isavuconazole Release Date: | Research | Inflammation & Immunology | Australia, Germany, Israel, Italy, Spain, Switzerland | |
PARP-Inhibitor Combination Treatments: Biomarker Testing, Safety, and Efficacy in a Rapidly Changing Metastatic Prostate Cancer Release Date: | Education | Oncology | USA | |
Pediatric pneumococcal carriage and serotype distribution surveillance: prospective studies in South-East Asia, 2025-2026 Release Date: | Research | Vaccines | India, Indonesia, Malaysia, Philippines, Singapore, Taiwan, Thailand, Vietnam | |
Advancing Health Care Professionals’ knowledge and understanding of adult and maternal vaccination against respiratory infection Release Date: | Education | Vaccines | Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Estonia, Finland, Greece, Hungary, Ireland, Israel, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Norway, Poland, Portugal, Romania, Slovakia (Slovak Republic), Slovenia, Ukraine | |
Review and analysis of serotype distribution and burden of pneumococcal disease in children younger than 5 years – Post vac era Release Date: | Research | Vaccines | Burkina Faso, Congo, The Democratic Republic, Cote D'ivoire, Ethiopia, Ghana, Mozambique, Pakistan, Senegal, Sudan, Tanzania, United Republic of | |
The Clinical Application of ATM-AVI in Patients with CRE Infections, including MBL-Producing CRE Release Date: | Research | Hospital | China, Hong Kong | |
COVID-19 Disease Burden on the High Risk Population Release Date: | Education | Vaccines | All | |
New Research Areas to Improve Diagnosis and Treatment of Inflammatory Bowel Disease Release Date: | Research | Inflammation & Immunology | USA |
Title | Grant Type | Focus Area | Country | Application Due Date |
---|---|---|---|---|
Phase I/II Clinical Trials of Axitinib in the Treatment of Melanoma, Hepatocellular Carcinoma and Colorectal Cancer | Research | Oncology | All, USA | |
Advances in Moderate-to-Severe Atopic Dermatitis for Dermatologists Release Date: | Education | Inflammation & Immunology | USA | |
Incorporating Biosimilar Treatment Options in Solid Tumor Education Programs Release Date: | Education | Oncology | All | |
NSCLC – Current Practice Considerations Release Date: | Education | Oncology | Austria, Belgium, Canada, Denmark, Finland, France, Germany, Greece, Ireland, Italy, Liechtenstein, Luxembourg, Mexico, Monaco, Netherlands, Norway, Portugal, Spain, Sweden, Switzerland, USA, United Kingdom | |
Gram Negatives Pathogens & Antimicrobial Resistance: Local Data Generation in Latin America Release Date: | Research | Hospital | Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Guatemala, Honduras, Mexico, Panama, Peru, Uruguay | |
Addressing Health Disparities in Inflammatory Bowel Disease Release Date: | Quality Improvement | Inflammation & Immunology | USA | |
Enduring SpA Programs Release Date: | Education | Inflammation & Immunology | All | |
Atopic Dermatitis Patient Education Release Date: | Education | Inflammation & Immunology | USA | |
Knowledge Gaps in Updated Pneumococcal Immunization Recommendations Release Date: | Education | Vaccines | USA | |
Prostate Cancer Disparities Project | Quality Improvement | Oncology | USA | |
Telehealth Solutions in Rheumatoid Arthritis for Improving Education and Patient Care (Emerging Markets) Release Date: | Education | Inflammation & Immunology | All | |
Telehealth Solutions in Atopic Dermatitis for Improving Education and Patient Care (Emerging Markets) Release Date: | Education | Inflammation & Immunology | All |